Published in Obesity and Diabetes Week, November 10th, 2008
"We show that loss of E2F1 in vivo blunts PDK4...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.